BOW vs TMO · P/E 16, rev $425.7M vs P/E 24, rev $44.56B
Bowhead Specialty Holdings Inc. (BOW) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Bowhead Specialty Holdings Inc. (BOW) is a insurance - property & casualty company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported BOW revenue for 2024-12-31 was $425.7M. Net income was $38.2M. Revenue was up 50.2% from 2023-12-31 to 2024-12-31. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
BOW currently screens at market cap $903.7M and trailing P/E 15.9. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the BOW and TMO stock pages for the full models.
Not investment advice.